AP1S3
AP-1 complex subunit sigma-3
Also known as: AP1S3_HUMAN, sigma1C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96PC3
- Gene
- AP1S3
- Ensembl
- ENSG00000152056
- Chromosome
- 2
- Canonical length
- 154 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a member of the adaptor-related protein complex 1, sigma subunit genes. The encoded protein is a component of adaptor protein complex 1 (AP-1), one of the AP complexes involved in claathrin-mediated vesicular transport from the Golgi or endosomes. Disruption of the pathway for display of HIV-1 antigens, which prevents recognition of the virus by cytotoxic T cells, has been shown to involve the AP-1 complex (PMID: 15569716). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Canonical amino-acid sequenceUniProt
154 residues, UniProt reviewed canonical sequence.
>Q96PC3|AP1S3
1 MIHFILLFSR QGKLRLQKWY ITLPDKERKK ITREIVQIIL SRGHRTSSFV DWKELKLVYK
61 RYASLYFCCA IENQDNELLT LEIVHRYVEL LDKYFGNVCE LDIIFNFEKA YFILDEFIIG
121 GEIQETSKKI AVKAIEDSDM LQEVSTVSQT MGERLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AP1S3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 46 nTPM
- thyroid gland: 13 nTPM
- stomach: 8.6 nTPM
- urinary bladder: 7 nTPM
- placenta: 5.7 nTPM
- kidney: 5 nTPM
Single-cell type
- loop of henle epithelial cells: 150 nCPM
- epididymal principal cells: 106 nCPM
- papillary tip epithelial cells: 89 nCPM
- cytotrophoblasts: 85 nCPM
- alveolar cells type 1: 77 nCPM
- mast cells: 66 nCPM
Immune cell
- basophil: 5.6 nTPM
- memory B-cell: 4.6 nTPM
- plasmacytoid DC: 3.8 nTPM
- naive B-cell: 2.5 nTPM
- neutrophil: 2.1 nTPM
- myeloid DC: 1.1 nTPM
Brain region
- cerebellum: 13 nTPM
- cerebral cortex: 12 nTPM
- basal ganglia: 12 nTPM
- amygdala: 12 nTPM
- hypothalamus: 12 nTPM
- medulla oblongata: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AP1S3.
Disease | AllUniProt
Conditions AP1S3 is implicated in, by any mechanism.
- Psoriasis 15, pustular (PSORS15) MIM:616106
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular protein transport
- melanosome assembly
- platelet dense granule organization
- protein targeting
- vesicle-mediated transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AP1S3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AP1S3 as an antibody target. Whether an autoantibody or antibody against AP1S3 could matter depends on whether native AP1S3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AP1S3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AP1S3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...